Editorial Comment

In the current issue Gill et al report long-term rates of RT in men enrolled in the PCM301 trial, which compared PGA by VTP and AS in men with low risk prostate cancer.1 They report that conversion rates to RT remained substantially lower at 2, 3 and 4 years of followup among men treated with VTP with the absolute risk reduction remaining constant at each year at 29%. Whether this demonstrates a delay in inevitable RT or whether some men will avoid RT altogether remains uncertain.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Adult Urology Source Type: research